New active substances that can block the replication of the SARS-CoV-2 coronavirus discovered in proof-of-concept study.
New active substances that can block the replication of the SARS-CoV-2 coronavirus discovered in proof-of-concept study.
Replacing animal testing with the ever-growing capabilities of AI and deep learning could help minimize the need for animals in scientific discovery.
Moisture-resistant mask filters made from compostable and abundant materials could help curb plastic pollution as a result of the pandemic.
A scientific detective story unearths how SARS-CoV-2 evolves new variants that evade antibodies.
Engineers and oncologists teamed up to develop a microfluidic chip capable of capturing the body’s natural killer immune cells to harvest their cancer-killing exosomes.
Demoted from her tenure track position in the mid 90s, Katalin Karikó persisted with her research into RNA therapeutics and is now senior vice president of BioNtech.
Nvel tuberculosis vaccine demonstrated strong immune response in mice.
The first digital CRISPR/Cas‐assisted assay that can detect SARS‐CoV‐2 in under 30 minutes.
Small changes in societies’ behaviors could lead to positive cascading effects that will mitigate climate change.
The Argentinean experience can inform experts on LEEN efforts to make industrial sectors more energy efficient in developing regions.